GT Biopharma Inc (GTBP)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

310 N. WESTLAKE BLVD. WESTLAKE VILLAGE, CA 91362

GT Biopharma, Inc. operates as a biotechnology company. The Company discovers, develops, and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions, and other unmet medical needs. GT Biopharma serves customers worldwide.

Data as of 2020-07-04
Market Cap9.898 Million Shares Outstanding70.699 Million Avg 30-day Volume107.421 Thousand
P/E Ratio Dividend Yield EPS-0.56
Price/Sales Price cash flow ratio Price free cash flow ratio-5.6
Book Value-0.29 Price to Tangible Book-0.5 Alpha-0.08
Short Interest Ratio0.0 % Short Interest to Float R-squared0.008197
BETA-0.687387 52-week High/Low0.27 / 0.065 Stddev0.323322
View SEC Filings from GTBP instead.
Q1 2020 All Institutions Hedge Funds 1
No data found for this quarter.
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding GTBP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GTBP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments